Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Grem

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|May 1, 1990
Levamisole as a therapeutic agent for colorectal carcinomaJ L Grem
Cancer Investigation|January 1, 1990
5-Fluorouracil and levamisole in colorectal carcinomaJ L Grem
Oncology (Williston Park, N.Y.)|March 1, 1991
Adjuvant treatment of node-positive colon carcinoma with levamisole and 5-fluorouracilJ L Grem
Seminars in Oncology|February 1, 1991
Current treatment approaches in colorectal cancerJ L Grem
Investigational New Drugs|November 18, 2000
5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical developmentJ L Grem
Seminars in Oncology|April 1, 1992
Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experienceJ L Grem
Cancer Treatment and Research|May 18, 1999
Recent insights into the molecular basis of intrinsic resistance of colorectal cancer: new challenges for systemic therapeutic approachesJ L Grem
Oncology (Williston Park, N.Y.)|February 28, 2001
Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancerJ L Grem
Seminars in Oncology|January 7, 1998
Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorinJ L Grem
Current Opinion in Oncology|July 1, 1994
Chemotherapy of advanced gastrointestinal cancerF Geoffroy, J L Grem
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|May 1, 1990
Levamisole as a therapeutic agent for colorectal carcinomaJ L Grem
Cancer Investigation|January 1, 1990
5-Fluorouracil and levamisole in colorectal carcinomaJ L Grem
Oncology (Williston Park, N.Y.)|March 1, 1991
Adjuvant treatment of node-positive colon carcinoma with levamisole and 5-fluorouracilJ L Grem
Seminars in Oncology|February 1, 1991
Current treatment approaches in colorectal cancerJ L Grem
Investigational New Drugs|November 18, 2000
5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical developmentJ L Grem
Seminars in Oncology|April 1, 1992
Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experienceJ L Grem
Cancer Treatment and Research|May 18, 1999
Recent insights into the molecular basis of intrinsic resistance of colorectal cancer: new challenges for systemic therapeutic approachesJ L Grem
Oncology (Williston Park, N.Y.)|February 28, 2001
Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancerJ L Grem
Seminars in Oncology|January 7, 1998
Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorinJ L Grem
Current Opinion in Oncology|July 1, 1994
Chemotherapy of advanced gastrointestinal cancerF Geoffroy, J L Grem
Pageof 12